blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4175654

EP4175654 - ANTISENSE OLIGONUCLEOTIDES TARGETING SARS-COV-2 [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  07.04.2023
Database last updated on 03.10.2024
FormerThe international publication has been made
Status updated on  11.02.2022
Most recent event   Tooltip14.09.2024Supplementary search reportpublished on 16.10.2024 [2024/42]
Applicant(s)For all designated states
The Regents of the University of California
1111 Franklin Street 12th Floor
Oakland CA 94607-5200 / US
For all designated states
Aalborg University
Fredrik Bajers Vej 7K
Aalborg Øst
9220 Copenhagen / DK
[2023/19]
Inventor(s)01 / NAAR, Anders, Michael
Berkeley, California 94704 / US
02 / KAUPPINEN, Sakari
9220 Copenhagen / DK
03 / ZHU, Chi
Berkeley, California 94704 / US
04 / KARSTENSEN, Kasper, Thystrup
9220 Copenhagen / DK
 [2023/19]
Representative(s)Maiwald GmbH
Grünstraße 25
40212 Düsseldorf / DE
[2023/19]
Application number, filing date21853242.213.07.2021
[2023/19]
WO2021US41503
Priority number, dateUS202063062417P06.08.2020         Original published format: US 202063062417 P
US202163147225P08.02.2021         Original published format: US 202163147225 P
[2023/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022031410
Date:10.02.2022
Language:EN
[2022/06]
Type: A1 Application with search report 
No.:EP4175654
Date:10.05.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 10.02.2022 takes the place of the publication of the European patent application.
[2023/19]
Search report(s)International search report - published on:US10.02.2022
(Supplementary) European search report - dispatched on:EP13.09.2024
ClassificationIPC:A61K35/76, A61K39/215, C07K16/10, C12N15/86
[2023/19]
CPC:
C12N15/1131 (EP,US); A61K9/0043 (US); A61P31/14 (US);
C12N2310/11 (EP,US); C12N2310/315 (EP); C12N2310/321 (US);
C12N2310/3231 (EP); C12N2310/3233 (US); C12N2310/341 (EP);
C12N2310/343 (EP); C12N2320/11 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/19]
TitleGerman:GEGEN SARS-COV-2 GERICHTETE ANTISENSE-OLIGONUKLEOTIDE[2023/19]
English:ANTISENSE OLIGONUCLEOTIDES TARGETING SARS-COV-2[2023/19]
French:OLIGONUCLÉOTIDES ANTISENS CIBLANT LE SARS-COV-2[2023/19]
Entry into regional phase06.02.2023National basic fee paid 
06.02.2023Search fee paid 
06.02.2023Designation fee(s) paid 
06.02.2023Examination fee paid 
Examination procedure06.02.2023Examination requested  [2023/19]
18.07.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
27.07.2023Renewal fee patent year 03
29.07.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US2006257852  (RAPPUOLI RINO [IT], et al) [X] 1-10, 19-20 * ; paragraphs [0405]-[0408], [1099], [1107], [1172], [1364], [1695] *;
 [Y]US2007238681  (DOBIE KENNETH W [US], et al) [Y] 1-3, 6, 8/2-3, 8/6, 9/2-3,9/6, 10/2-3, 10/6, 19-24 * ; paragraphs [0015], [0018], [0082], [0094]-[0095], [0108] . *;
 [Y]  - MOITRA, P et al., "Selective Naked-Eye Detection of SARS-CoV 2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles", ACS Nano, (20200623), vol. 14, no. 6, doi:10.1021/acsnano.0c03822, pages 7617 - 7627, XP055796333 [Y] 1-10, 19-24 * . *

DOI:   http://dx.doi.org/10.1021/acsnano.0c03822
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.